Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Clinical Practice Guidelines

Back to Topics
Contents
0%

Clinical Practice Guidelines

Comprehensive guide to clinical practice guidelines including development methodology, GRADE system, implementation, and critical appraisal in orthopaedic surgery.

complete
Updated: 2025-12-24
High Yield Overview

CLINICAL PRACTICE GUIDELINES

Guideline Development | GRADE | Implementation | Critical Appraisal

GRADEGrading of Recommendations Assessment
StrongStrong Recommendation (Do it)
WeakWeak Recommendation (Consider it)
AGREE IIAppraisal Tool for Guidelines

Recommendation Strength by Evidence Quality

Strong Recommendation, High Quality Evidence
PatternClear benefit, strong evidence
TreatmentDo it - implement in practice
Strong Recommendation, Low Quality Evidence
PatternLarge effect despite weak evidence
TreatmentDo it - ethical imperative or large effect
Weak Recommendation, High Quality Evidence
PatternSmall benefit, close balance
TreatmentConsider it - shared decision-making
Weak Recommendation, Low Quality Evidence
PatternUncertain benefit, weak evidence
TreatmentConsider it - very context-dependent

Critical Must-Knows

  • Clinical Practice Guideline (CPG): Systematically developed statements to assist practitioner and patient decisions about appropriate care for specific clinical circumstances.
  • GRADE System: Separates evidence quality (High/Moderate/Low/Very Low) from recommendation strength (Strong/Weak).
  • Strong Recommendation: Clinicians should follow in most patients. Requires large benefit, high-quality evidence, or ethical imperative.
  • Weak Recommendation: Different choices for different patients. Requires shared decision-making based on patient values.
  • Implementation Gap: Guidelines often not followed in practice due to barriers (awareness, agreement, adoption, adherence).

Examiner's Pearls

  • "
    Strong recommendation does NOT always require high-quality evidence (can have low quality if large effect)
  • "
    Guideline development panels should be multidisciplinary and free from conflicts of interest
  • "
    AGREE II tool assesses guideline quality across 6 domains (scope, stakeholder involvement, rigor, clarity, applicability, independence)
  • "
    Local adaptation of guidelines needed to match Australian context (AOANJRR data, PBS, Medicare)

Clinical Imaging

Imaging Gallery

Screen capture of the information displayed on the CPGame when consensus was not reached within a team.
Click to expand
Screen capture of the information displayed on the CPGame when consensus was not reached within a team.Credit: Heselmans A et al. via J. Med. Internet Res. via Open-i (NIH) (Open Access (CC BY))
Screen capture of the final page in the CPGame application, showing the answers of all participants, the level of evidence, and the level of agreement between participants.
Click to expand
Screen capture of the final page in the CPGame application, showing the answers of all participants, the level of evidence, and the level of agreementCredit: Heselmans A et al. via J. Med. Internet Res. via Open-i (NIH) (Open Access (CC BY))
Strategy for management of recurrent urinary tract infection (UTI) in women derived from recommendations from the Infectious Diseases Society of America, European Society of Clinical Microbiology and
Click to expand
Strategy for management of recurrent urinary tract infection (UTI) in women derived from recommendations from the Infectious Diseases Society of AmeriCredit: Gupta K et al. via BMJ via Open-i (NIH) (Open Access (CC BY))

GRADE System in Depth

Quality of Evidence

Four Levels: High, Moderate, Low, Very Low

Determining Starting Quality

RCT: Start at HIGH quality

Observational Study: Start at LOW quality

Then Apply Modifiers: Downgrade or upgrade based on factors.

This establishes baseline before applying judgment.

Factors that Downgrade Evidence (RIIIP)

Downgrade Factors

FactorCriterionDowngrade By
Risk of BiasSerious limitations (lack of blinding, high attrition)Minus 1 or minus 2 levels
InconsistencyUnexplained heterogeneity across studies (I² greater than 50%)Minus 1 or minus 2 levels
IndirectnessPICO mismatch (different population, surrogate outcome)Minus 1 or minus 2 levels
ImprecisionWide confidence intervals, small sample, few eventsMinus 1 or minus 2 levels
Publication BiasFunnel plot asymmetry, suspected negative unpublished studiesMinus 1 level

Each factor can reduce quality by 1 or 2 levels.

Factors that Upgrade Evidence

Upgrade Factors

FactorCriterionUpgrade By
Large EffectRR greater than 2 or less than 0.5 with no plausible confoundersPlus 1 level
Very Large EffectRR greater than 5 or less than 0.2Plus 2 levels
Dose-ResponseClear dose-response gradientPlus 1 level
Residual ConfoundingAll plausible confounders would REDUCE effect (bias toward null)Plus 1 level

Upgrades typically apply to observational studies with exceptional features.

Recommendation Strength

Two Levels: Strong or Weak (for or against)

Strong vs Weak Recommendations

AspectStrong RecommendationWeak Recommendation
WordingWe recommend... / Clinicians should...We suggest... / Clinicians might consider...
Meaning for PatientsMost patients would want this interventionDifferent choices for different patients based on values
Meaning for CliniciansMost patients should receive this interventionEngage in shared decision-making, individualize
ImplicationsCan be used as performance measure or quality indicatorShould NOT be used as performance measure (patient choice matters)

Wording signals strength - surgeons must recognize difference.

Appraising Guideline Quality

AGREE II Tool

Purpose: Assess methodological rigor and transparency of guidelines.

Six Domains (23 items total):

Domain 1: Scope and Purpose

Questions:

  • Are objectives clearly described?
  • Are health questions covered by guideline specified?
  • Is target population clearly described?

Why Important: Clarity on who guideline applies to prevents misapplication.

Well-defined scope prevents guideline creep.

Domain 2: Stakeholder Involvement

Questions:

  • Does development group include all relevant professional groups?
  • Were patient views and preferences sought?
  • Is target user clearly defined?

Why Important: Multidisciplinary input and patient involvement ensure relevance and feasibility.

Patient representatives are essential for patient-centered guidelines.

Domain 3: Rigor of Development (MOST IMPORTANT)

Questions:

  • Were systematic methods used to search for evidence?
  • Were criteria for selecting evidence clearly described?
  • Were strengths and limitations of evidence clearly described?
  • Were methods for formulating recommendations explicit?
  • Were health benefits, side effects, and risks considered?
  • Is there explicit link between recommendations and supporting evidence?
  • Was guideline externally reviewed before publication?
  • Is there procedure for updating?

Why Important: This domain assesses whether guideline is evidence-based or opinion-based.

Rigor domain separates high-quality guidelines from consensus documents.

Domain 4: Clarity of Presentation

Questions:

  • Are recommendations specific and unambiguous?
  • Are different management options clearly presented?
  • Are key recommendations easily identifiable?

Why Important: Unclear recommendations cannot be implemented.

Format matters - clinicians need actionable, clear guidance.

Domain 5: Applicability

Questions:

  • Are facilitators and barriers to application discussed?
  • Are implementation tools provided?
  • Are resource implications considered?
  • Are criteria for monitoring provided?

Why Important: Evidence-based recommendations fail if not implementable.

Implementation science critical for guideline uptake.

Domain 6: Editorial Independence

Questions:

  • Is funding source clearly stated?
  • Have competing interests been recorded and addressed?

Why Important: Industry funding or author conflicts bias recommendations.

Independence is essential for trustworthy guidelines.

Scoring: Each item rated 1-7. Domain scores calculated as percentage of maximum possible.

Overall Assessment: Would you recommend this guideline for use? Yes / Yes with modifications / No

AGREE II is the gold standard for guideline appraisal.

Implementation and Barriers

Why Guidelines Fail

Implementation Barriers

BarrierExampleSolution
Awareness (Do not know)Clinicians unaware guideline existsActive dissemination: conferences, emails, clinical reminders
Agreement (Disagree)Clinicians disagree with recommendationsLocal adaptation, opinion leader endorsement, involve skeptics in process
Adoption (Too difficult)Requires resources or system changes not availableSimplify, provide tools, address local barriers
Adherence (Forget)Intention-behavior gap, revert to old habitsClinical decision support, reminders, audit and feedback

Implementation Strategies

Passive Dissemination: Publication, mailing - LOW effectiveness.

Active Strategies:

  • Clinical Decision Support: Electronic alerts, order sets
  • Audit and Feedback: Compare performance to guideline, provide feedback
  • Academic Detailing: One-on-one education with opinion leaders
  • Multifaceted Interventions: Combine strategies - MOST effective

Understanding barriers and targeting interventions improves uptake.

Anatomy

Structure of Clinical Practice Guidelines

Essential Components:

  1. Clinical question (PICO): Population, Intervention, Comparison, Outcome
  2. Evidence summary: Systematic review of available evidence
  3. Evidence quality assessment: GRADE or similar system
  4. Recommendation statements: Clear, actionable guidance
  5. Rationale: Explanation linking evidence to recommendation

Strength of recommendation:

  • Strong: Benefits clearly outweigh harms
  • Weak/Conditional: Balance of benefits and harms is close

GRADE Quality of Evidence

Evidence Quality Levels:

High: RCTs without serious limitations

  • Further research unlikely to change confidence in effect

Moderate: RCTs with limitations or strong observational

  • Further research likely to change confidence

Low: Observational studies

  • Further research very likely to change effect estimate

Very Low: Case series, expert opinion

  • Estimate of effect is very uncertain

Recommendation vs Evidence Quality

Strong recommendation CAN come from low-quality evidence when: (1) benefits clearly outweigh harms even with uncertainty, (2) ethical considerations mandate action, or (3) resource implications favor intervention. Example: Prophylactic antibiotics for open fractures (strong recommendation) despite limited RCT evidence.

PICO Framework

PICO Framework for Clinical Questions

ComponentDefinitionExample (VTE Prophylaxis)
P - PopulationTarget patient groupAdults undergoing major orthopaedic surgery
I - InterventionTreatment or exposurePharmacological thromboprophylaxis
C - ComparisonAlternative (if applicable)No prophylaxis or mechanical only
O - OutcomeMeasurable health outcomesSymptomatic DVT/PE, major bleeding

Evidence to Decision Framework

GRADE Evidence-to-Decision Framework:

Beyond evidence quality, considers:

  1. Benefits and harms: Balance of desirable and undesirable effects
  2. Values and preferences: How important are outcomes to patients
  3. Resources: Cost and feasibility
  4. Equity: Impact on health disparities
  5. Acceptability: Stakeholder acceptability
  6. Feasibility: Implementation barriers

Key insight: Two guidelines can make different recommendations from the same evidence based on local values, resources, or priorities.

Classification

Types of Clinical Guidelines

By Scope:

  • Condition-specific: Single disease or injury (e.g., ACL rupture)
  • Procedure-specific: Single intervention (e.g., TKA)
  • Cross-cutting: Apply across conditions (e.g., VTE prophylaxis)

By Developer:

  • Professional societies (AAOS, AOA)
  • Government agencies (NHMRC, NICE)
  • Health systems (hospital-specific)
  • Cochrane groups

AGREE II Domains

Guideline Quality Assessment:

  1. Scope and Purpose (23%): Objectives, questions, population
  2. Stakeholder Involvement (18%): Relevant expertise, patient input
  3. Rigor of Development (27%): Evidence search, grading, updating
  4. Clarity of Presentation (13%): Specific, unambiguous recommendations
  5. Applicability (12%): Implementation advice, barriers, costs
  6. Editorial Independence (7%): Conflicts of interest, funding

AGREE II Threshold

AGREE II scores above 60% in Rigor of Development indicate a methodologically sound guideline. Many orthopaedic guidelines score poorly on this domain. Always check evidence grading and systematic review methodology before applying recommendations.

Levels of Evidence Classification

Oxford Levels of Evidence

LevelStudy DesignExample in Orthopaedics
1aSystematic review of RCTs with homogeneityCochrane review of TXA in arthroplasty
1bIndividual RCT with narrow CISPRINT trial (reaming in tibial nailing)
2aSystematic review of cohort studiesMeta-analysis of arthroplasty registry data
2bIndividual cohort study or low-quality RCTRegistry study of bearing surface outcomes
3aSystematic review of case-control studiesMeta-analysis of risk factors for PJI
3bIndividual case-control studyCase-control study of implant loosening
4Case series, poor cohort/case-controlCase series of new surgical technique
5Expert opinion without critical appraisalConsensus statement

Clinical Relevance and Applications

Applying Guidelines in Orthopaedic Practice

Strong Recommendations:

  • Apply to most patients unless contraindicated
  • Example: "We recommend VTE prophylaxis for major orthopaedic surgery" - give prophylaxis to essentially all patients

Weak Recommendations:

  • Shared decision-making required
  • Example: "We suggest arthroscopic debridement may be considered for mechanical symptoms in early OA" - discuss alternatives, patient values matter

No Recommendation:

  • Evidence insufficient to guide practice
  • Use clinical judgment, inform patient of uncertainty

Guideline Limitations

Not Cookbook Medicine:

  • Guidelines inform, not dictate decisions
  • Individual patient factors may override recommendations
  • Rare complications or comorbidities may not be addressed

When Guidelines Don't Apply:

  • Atypical patient characteristics (age, comorbidities)
  • Patient preferences differ from guideline assumptions
  • Local resources unavailable
  • New evidence published since guideline development

Wise clinicians use guidelines as a starting point, then individualize based on patient-specific factors.

Australian Context

Key Australian Guideline Bodies

ACSQHC

Australian Commission on Safety and Quality in Health Care. Develops national standards and guidelines. Examples: Surgical Safety Checklist, Antimicrobial Stewardship.

NHMRC

National Health and Medical Research Council. Funds research, develops evidence-based guidelines. Example: Clinical Practice Guidelines Portal.

AOA

Australian Orthopaedic Association. Specialty-specific guidelines for fracture management, arthroplasty, consent. Incorporates AOANJRR data.

eTG

Therapeutic Guidelines (eTG). Antibiotic prophylaxis, DVT prophylaxis, pain management. Updated regularly, widely used in Australian hospitals.

Local Adaptation

International guidelines require local adaptation for the Australian context.

Key Considerations:

  • AOANJRR registry data specific to Australian practice patterns
  • PBS medication reimbursement policies affect drug recommendations
  • Australian injury epidemiology differs from US/UK populations
  • Healthcare system structure influences implementation feasibility

Example: International guideline recommends cemented THA for over 65 years. AOANJRR data shows similar revision rates for uncemented in Australian population → Local adaptation may recommend either option based on local evidence.

Always consider local context when applying international guidelines.

Investigations

Finding Relevant Guidelines

Key Resources:

  • TRIP Database: Searches multiple guideline databases
  • NHMRC Clinical Guidelines Portal: Australian guidelines
  • NICE Evidence: UK guidelines, highly rigorous
  • AAOS Clinical Practice Guidelines: Orthopaedic-specific

Search Strategy:

  • Start with specialty society guidelines
  • Check government/national guideline databases
  • Search PubMed for "clinical practice guideline" + topic

Evaluating Guideline Quality

Quick Assessment:

  1. Who developed it? (reputation, expertise)
  2. When updated? (currency, within 5 years ideal)
  3. Evidence grading used? (GRADE preferred)
  4. Conflicts declared? (funding source, disclosures)

Formal Assessment:

  • AGREE II instrument (6 domains, 23 items)
  • Score above 60% in Rigor indicates quality

Check Currency First

Guidelines more than 5 years old may be outdated. Always check the publication date and whether there have been subsequent updates or superseding guidelines. Key orthopaedic guidelines (AAOS, NICE) are typically reviewed every 3-5 years.

Systematic Search for Guidelines

Guideline Database Resources

DatabaseCoverageStrengthsLimitations
NHMRC PortalAustralian guidelinesLocal relevance, PBS alignedLimited orthopaedic specific content
NICE EvidenceUK NHS guidelinesRigorous methodology, well-maintainedUK-specific recommendations
AAOS GuidelinesUS orthopaedic practiceSpecialty-specific, GRADE methodologyMay not apply to all populations
Cochrane LibrarySystematic reviewsGold standard methodologyReviews, not recommendations
Guidelines International NetworkGlobal guidelinesComprehensive, searchableVariable quality

Management

📊 Management Algorithm
Management algorithm for Clinical Practice Guidelines
Click to expand
Management algorithm for Clinical Practice GuidelinesCredit: OrthoVellum

Implementing Guidelines

Key Strategies:

  • Education and dissemination
  • Clinical decision support and reminders
  • Audit and feedback
  • Local champions and opinion leaders
  • Multifaceted interventions (most effective)

Individualizing Care

When to deviate:

  • Patient contraindications
  • Patient values differ
  • Resources unavailable
  • New evidence since publication

Documentation: Record rationale for deviation

Guidelines Apply to Populations

Strong recommendations don't mean every patient must receive the intervention. Individualize based on patient factors and preferences, documenting rationale when deviating.

Shared Decision-Making

Surgical Technique

Guidelines in Surgical Decisions

Addressed by guidelines:

  • Indications for surgery
  • VTE and antibiotic prophylaxis
  • Perioperative care protocols
  • Enhanced recovery pathways

Often NOT addressed:

  • Specific surgical techniques
  • Implant selection
  • Approach comparisons

WHO Surgical Safety Checklist

Evidence-based guideline implementation:

  • Sign in: Identity, consent, site marking
  • Time out: Team briefing, antibiotic timing
  • Sign out: Counts, recovery plan

Impact: 36% reduction in surgical mortality

Technique Guidelines Limited

Most surgical technique recommendations are consensus-based. Guidelines typically address indications and perioperative care rather than operative technique. Surgical technique relies on training and observational evidence.

AAOS Guideline Examples

Key AAOS Recommendations

TopicRecommendationStrength
Hip FractureEarly surgery within 24-48hStrong
Knee OAAgainst arthroscopic debridementStrong
VTE ProphylaxisPharmacological or mechanicalModerate
Rotator CuffExercise before surgeryModerate

Complications

Problems with Guidelines

Misapplication:

  • Applying to wrong population
  • Using outdated guidelines
  • Ignoring individual factors

Overreliance:

  • "Cookbook medicine"
  • Defensive practice
  • Ignoring clinical judgment

Guideline Limitations

Inherent issues:

  • Evidence gaps
  • Lag time in development
  • Population vs individual focus

Quality concerns:

  • Conflicts of interest
  • Industry influence
  • Variable methodology

Conflicts of Interest

Always check conflict of interest disclosures. Industry-funded guidelines may overestimate treatment benefits.

Medicolegal Considerations

Postoperative Care

Guideline-Directed Postop Care

Key areas:

  • VTE prophylaxis (duration, agent)
  • Antibiotic prophylaxis
  • Pain management protocols
  • ERAS pathways

Monitoring Adherence

Quality indicators:

  • VTE prophylaxis timing
  • Antibiotic compliance
  • SSI rates
  • Readmission rates

ERAS Protocols

Enhanced Recovery After Surgery bundles combine multiple guideline recommendations. Shown to reduce complications, length of stay, and costs in arthroplasty.

VTE Prophylaxis Guideline Comparison

VTE Prophylaxis by Guideline

GuidelineAgentsDuration
ACCPLMWH, fondaparinux, warfarin, aspirin10-35 days
AAOSPharmacological or mechanicalVariable
NICELMWH, rivaroxaban14-35 days
eTG (Australia)LMWH, rivaroxaban, aspirin28-35 days

Outcomes

Guideline Impact

Benefits of implementation:

  • Reduced variation in care
  • Improved best practice adherence
  • Measurable outcome improvements

Examples:

  • Surgical checklist: 36% mortality reduction
  • VTE guidelines: Reduced PE rates

Measuring Effectiveness

Process measures:

  • Guideline awareness
  • Compliance rates

Outcome measures:

  • Complication rates
  • Patient-reported outcomes
  • Cost-effectiveness

Implementation Success Factors

Evidence Base

GRADE Working Group Methodology

1
Guyatt GH, Oxman AD, Vist GE, et al • BMJ (2008)
Key Findings:
  • GRADE provides transparent, systematic framework for grading evidence and recommendations
  • Separates evidence quality (confidence in effect) from recommendation strength (should we do it)
  • Considers benefits, harms, values, costs, equity, feasibility
  • Adopted by WHO, Cochrane, 100+ guideline organizations globally
  • Strong recommendation requires large benefit, minimal harm, aligned values, OR ethical imperative
Clinical Implication: GRADE ensures guideline recommendations are evidence-based, transparent, and consider patient values and resource use.
Limitation: Time-intensive, requires expert panel and systematic reviews - not feasible for all clinical questions.

AGREE II Instrument for Guideline Appraisal

5
Brouwers MC, Kho ME, Browman GP, et al • CMAJ (2010)
Key Findings:
  • AGREE II assesses guideline quality across 6 domains (23 items)
  • Rigor of development domain most important (systematic evidence synthesis, explicit methods)
  • High inter-rater reliability (ICC greater than 0.80)
  • Used globally to appraise guideline quality
  • Provides standardized approach to assess which guidelines are trustworthy
Clinical Implication: Use AGREE II to critically appraise guidelines before adopting in practice. Focus on rigor and editorial independence.
Limitation: Does not assess clinical content accuracy - only methodological quality.

Knowledge-to-Practice Gap in Guidelines

3
Cabana MD, Rand CS, Powe NR, et al • JAMA (1999)
Key Findings:
  • Systematic review of barriers to physician adherence to clinical practice guidelines
  • Barriers: Lack of awareness (do not know), familiarity (not read), agreement (disagree), self-efficacy (cannot do), outcome expectancy (will not help), inertia (forget)
  • Passive dissemination ineffective - active implementation strategies needed
  • Multifaceted interventions more effective than single-strategy approaches
Clinical Implication: Guideline development alone insufficient - active implementation strategies required to change practice.
Limitation: Heterogeneous definitions of adherence and barriers - difficult to synthesize solutions.

Exam Focus

MCQ Practice Points

GRADE Evidence vs Recommendation

Q: Can a guideline make a strong recommendation based on low-quality evidence? A: Yes - GRADE separates evidence quality (confidence in effect) from recommendation strength (should we do it). Strong recommendation possible with low-quality evidence if there is a large magnitude of effect, ethical imperative, or clear benefit-harm balance favoring intervention. Example: Strong recommendation for surgery in displaced fractures despite lack of RCTs.

AGREE II Domains

Q: What is the most important AGREE II domain for assessing guideline quality? A: Rigor of Development - assesses whether systematic methods were used to search for evidence, appraise quality, link evidence to recommendations, and formulate recommendations using explicit criteria. This distinguishes evidence-based guidelines from expert consensus documents.

Implementation Barriers

Q: What are the main barriers to guideline implementation? A: The 4 As: Awareness (clinicians do not know guideline exists), Agreement (disagree with recommendations), Adoption (too difficult to implement due to resources or system barriers), Adherence (forget to apply or revert to old habits). Multifaceted active implementation strategies needed.

Guideline Updating

Q: How often should clinical practice guidelines be updated? A: Guidelines should be reassessed every 2-3 years and formally updated every 3-5 years. Living guidelines use continuous surveillance to update recommendations as new evidence emerges. A guideline is considered outdated if it has not been updated within 5 years or if substantial new evidence contradicts current recommendations.

Conflict of Interest

Q: How should conflicts of interest be managed in guideline development? A: Panel members should declare all financial and intellectual COI at the outset. Those with significant COI should recuse from voting on related recommendations. The chair of the guideline panel should ideally be free from relevant COI. All declarations should be publicly available in guideline documentation. COI management is a key domain assessed by AGREE II.

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

EXAMINER

"How do you critically appraise a clinical practice guideline?"

EXCEPTIONAL ANSWER
I would use the AGREE II instrument, which assesses guidelines across 6 domains. First, I would evaluate Scope and Purpose - is the clinical question clearly defined using PICO format? Second, Stakeholder Involvement - were appropriate experts and patient representatives included? Third, and most important, Rigor of Development - was there a systematic evidence search, clear criteria for evidence selection, explicit links between evidence and recommendations, and a plan for updating? Fourth, Clarity of Presentation - are recommendations specific and unambiguous? Fifth, Applicability - are implementation barriers and resource implications addressed? Sixth, Editorial Independence - are conflicts of interest declared and managed? A high-quality guideline should score above 60% in Rigor of Development. I would also check if the guideline uses GRADE methodology for evidence grading.
KEY POINTS TO SCORE
Use AGREE II instrument (6 domains)
Rigor of Development is most important domain
Check for systematic evidence search and explicit grading
Assess conflict of interest management
Look for currency - when was it last updated
COMMON TRAPS
✗Accepting guidelines without critical appraisal
✗Not checking for conflicts of interest
✗Using outdated guidelines without checking for updates
VIVA SCENARIOStandard

EXAMINER

"A patient asks about a new treatment they read about online. How do you use clinical practice guidelines to inform your discussion?"

EXCEPTIONAL ANSWER
I would first search for relevant clinical practice guidelines from reputable sources - starting with specialty societies like AAOS, then checking national guideline databases like NHMRC or NICE. I would assess the guideline quality using AGREE II principles - checking the evidence base, currency, and conflict of interest disclosures. If a high-quality guideline addresses the treatment, I would use its recommendation to frame the discussion with the patient, explaining the strength of recommendation and quality of evidence. If the treatment is too new to be in guidelines, I would explain this honestly and discuss the available evidence, its limitations, and the uncertainty around outcomes. I would also discuss how this fits with the patient's individual circumstances and preferences - recognizing that guidelines inform but don't dictate individual decisions.
KEY POINTS TO SCORE
Search specialty societies then national databases
Assess guideline quality (AGREE II principles)
Check currency - new treatments may not be addressed
Explain recommendation strength and evidence quality to patient
Individualize based on patient factors and preferences
COMMON TRAPS
✗Blindly following guidelines without individualizing
✗Using outdated guidelines for new treatments
✗Not explaining uncertainty when guidelines don't address the question
VIVA SCENARIOStandard

EXAMINER

"How do you approach shared decision-making when guidelines make a weak recommendation?"

EXCEPTIONAL ANSWER
Weak recommendations indicate that the balance of benefits and harms is close, or that patient values vary significantly. In these situations, I engage in explicit shared decision-making. I present the options, explain the evidence quality and trade-offs, and explore what matters most to the patient. For example, with VTE prophylaxis after arthroplasty, I would discuss the bleeding risk versus DVT risk, duration of prophylaxis, and patient factors that might tip the balance. The final decision reflects both evidence and individual patient values.
KEY POINTS TO SCORE
Weak recommendations require shared decision-making
Present options with evidence quality
Explore patient values and preferences
Final decision reflects both evidence and individual factors
COMMON TRAPS
✗Treating weak recommendations as strong
✗Not exploring patient preferences
✗Deciding unilaterally without discussion
VIVA SCENARIOStandard

EXAMINER

"You deviate from a guideline and the patient has a complication. How do you defend your decision?"

EXCEPTIONAL ANSWER
I would demonstrate awareness of the guideline, document patient-specific reasons for deviation, and show shared decision-making where applicable. Guidelines inform standard of care but don't define it absolutely. Reasonable deviation with documented rationale is defensible.
KEY POINTS TO SCORE
Show awareness of guideline
Document patient-specific reasons
Demonstrate shared decision-making
Guidelines inform but don't define standard of care
COMMON TRAPS
✗Claiming ignorance of guidelines
✗No documentation of rationale
✗Suggesting guidelines don't matter
VIVA SCENARIOStandard

EXAMINER

"How would you implement a new guideline in your department?"

EXCEPTIONAL ANSWER
I would use a multifaceted approach: identify local champions, educate through presentations and case discussions, integrate into workflow with protocols and checklists, audit compliance with feedback to the team, and address barriers including resource constraints and disagreements. Evidence shows multifaceted interventions are more effective than passive dissemination alone.
KEY POINTS TO SCORE
Identify local champions
Educate through multiple channels
Integrate into workflow
Audit and provide feedback
Address barriers proactively
COMMON TRAPS
✗Only sending an email (passive dissemination)
✗Mandating without addressing barriers
✗Not measuring implementation success

CLINICAL PRACTICE GUIDELINES

High-Yield Exam Summary

Guideline Definition and Purpose

  • •CPG = Systematically developed statements to guide clinical decisions
  • •Based on systematic review of evidence and explicit consideration of benefits/harms
  • •Purpose: Reduce unwarranted variation, improve quality, inform policy
  • •Should be updated every 3-5 years as new evidence emerges
  • •Distinguish from consensus statements (opinion-based, not systematic)

GRADE System

  • •Evidence Quality: High/Moderate/Low/Very Low (confidence in effect estimate)
  • •Recommendation Strength: Strong/Weak (should we do it?)
  • •RCT starts at High, Observational starts at Low, then apply modifiers
  • •Downgrade for: RIIIP (Risk of bias, Inconsistency, Indirectness, Imprecision, Publication bias)
  • •Strong recommendation possible with low evidence if large effect or ethical imperative

Strong vs Weak Recommendations

  • •Strong: We recommend / Most patients should receive / Can use as quality measure
  • •Weak: We suggest / Different choices for different patients / Shared decision-making
  • •Strong requires: Large benefit, minimal harm, aligned values, feasible, OR ethical imperative
  • •Weak: Close benefit-harm balance, varied patient values, high cost, or uncertain evidence
  • •Wording signals strength - clinicians must recognize difference

AGREE II Quality Appraisal

  • •6 domains: Scope, Stakeholder involvement, Rigor (most important), Clarity, Applicability, Independence
  • •Rigor domain: Systematic search, explicit methods, evidence-to-recommendation link, external review, update plan
  • •Editorial independence: Funding declared, conflicts managed, majority non-conflicted
  • •Patient involvement essential for patient-centered guidelines
  • •Overall assessment: Recommend for use / With modifications / Do not recommend

Implementation Barriers and Solutions

  • •4 As: Awareness, Agreement, Adoption, Adherence
  • •Passive dissemination (publication, mailing) = ineffective
  • •Active strategies: Clinical decision support, audit-feedback, academic detailing, reminders
  • •Multifaceted interventions (combine strategies) most effective
  • •Local adaptation needed to address barriers and context

Australian Context

  • •ACSQHC: National safety and quality standards
  • •NHMRC: Evidence-based guideline development and portal
  • •AOA: Orthopaedic specialty guidelines, AOANJRR data
  • •eTG: Antibiotic prophylaxis, DVT prophylaxis, pain management
  • •Adapt international guidelines for AOANJRR data, PBS, Australian context
Quick Stats
Reading Time92 min
Related Topics

Articular Cartilage Structure and Function

Bending Moment Distribution in Fracture Fixation

Biceps Femoris Short Head Anatomy

Biofilm Formation in Orthopaedic Infections